Sputnik V 75 percent effective against Omicron: Vaccine developer
Moscow: The effectiveness of the Sputnik V Covid-19 vaccine against the Omicron coronavirus variant is 75 per cent, Alexander Gintsburg, the head of Russia's Gamaleya Research Center, said on Tuesday.
The Sputnik V effectiveness against Omicron decreases by eight times but it is still enough for protection, Gintsburg said, adding that the effectiveness of other vaccines decreases by 21 times.
Read also: Gamaleya Center study claims Sputnik V effective against Omicron
The Sputnik V vaccine is based on a proven well-studied human adenovirus vector platform; these vectors cause the common cold and have plagued humanity for millennia. A storage temperature of +2…+8 °C allows the vaccine to be stored in a regular refrigerator without the need to invest in additional cold chain infrastructure.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.